CARBOLITH
BAUSCH HEALTH, CANADA INC.
View this drug's full profile page →
This is a national manufacturer shortage report. It does not confirm whether the product is unavailable at your local pharmacy — call ahead or ask your pharmacist.
Quick answers
Is CARBOLITH discontinued in Canada?
Yes. The manufacturer has reported to Health Canada that CARBOLITH 300MG has been permanently discontinued (last updated January 9, 2025). It is not expected to come back, so talk to your pharmacist or doctor about an alternative.
Why is CARBOLITH not available?
The reason the manufacturer reported: Business reasons.
Other Products Containing the Same Active Ingredient
These are other Health Canada-approved human drug products containing the same active ingredient, not currently reported in shortage. Strength, dosage form, and route can still differ — ask your pharmacist whether any of these are appropriate for you. This isn't a guarantee of current stock.
Closest Matches
LITHIZINE CAP 300MG
LABS MANEY PAUL LABS, DIVISION OF 471449 (ONT) LTEE/LTD.
PHL-LITHIUM CARBONATE
PHARMEL INC
DOM-LITHIUM CARBONATE
DOMINION PHARMACAL
PAL-LITHIUM CARBONATE
PALADIN PHARMA INC.
Other Products
DURALITH TAB 300MG
JANSSEN INC
LITHMAX
AA PHARMA INC
What this means
Does this mean I need to switch medications right away?
Not necessarily right away, but this product will not be returning to the market.
What should I do?
Talk to your pharmacist or prescriber about your options well before your current supply runs out.
DIN
00236683
Strength
300MG
Dosage Form
CAPSULE
Route
ORAL
Active Ingredient
LITHIUM CARBONATE
Tier
Unrated
Last Updated
2025-01-09
Reason for Shortage
Business reasons
Past Reports for This Drug
CARBOLITH has 3 shortage/discontinuation reports on file — this is one of them.
Other Products from BAUSCH HEALTH, CANADA INC.
Other Health Canada-approved products made by the same manufacturer — not necessarily related to this shortage, and not necessarily in shortage themselves.